Nafamostat, CAS [[81525-10-2]]

Produktübersicht

• Artikelname: Nafamostat, CAS [[81525-10-2]]
• Artikelnummer: TGM-T23052
• Hersteller Artikelnummer: T23052
• Alternativnummer: TGM-T23052-1MG,TGM-T23052-5MG,TGM-T23052-10MG,TGM-T23052-25MG,TGM-T23052-50MG,TGM-T23052-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Nafamostat is a synthetic serine protease inhibitor and an anticoagulant used in haemodialysis. It induces apoptosis by upregulating TNFR1 expression, inhibits NF-kappaB activity by blocking IkappaBalpha phosphorylation, and can also inhibit SARS-CoV-2 and COVID-19.

Produkteigenschaften

• Molekulargewicht: 347.37
• CAS Nummer: [81525-10-2]
• Formel: C19H17N5O2
• Target-Kategorie: SARS-CoV|||Anti-infection|||TNF|||Apoptosis|||Serine Protease|||NF-kappaB

Bilder

T23052

T23052